use-of-alirocumab-for-the-secondary-prevention-of-cardiovascular-disease-in-a-patient-with-end-stage-renal-disease-on-hemodialysis
Author(s) -
Io Chon Vong,
Man Fong Chu,
Màrio Évora,
Weng Chio,
Weng Chio Tam
Publication year - 2021
Publication title -
malaysian journal of pharmacy
Language(s) - Uncategorized
Resource type - Journals
ISSN - 1675-3666
DOI - 10.52494/cxzk2633
Subject(s) - medicine , alirocumab , dyslipidemia , hemodialysis , coronary artery disease , rosuvastatin , end stage renal disease , kidney disease , diabetes mellitus , adverse effect , disease , cardiology , intensive care medicine , lipoprotein , cholesterol , endocrinology , apolipoprotein a1
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom